ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2085

Estimating the Association between Effusion-synovitis and Knee Pain in a Subset of Participants with Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative (OAI)

Dagoberto Robles1, Greg Gilles2, Nathaniel H. Christiansen3, Luke Grawer4, Karim Jayyusi4, Ali Shaikh4, Rongrong Tang5, Mihra S. Taljanovic4, Jeffrey Duryea6, Edward J. Bedrick5 and C. Kent Kwoh7, 1University of Arizona, Tucson, AZ, 2University of Arizona Arthritis Center, The University of Arizona College of Medicine, Tucson, AZ, 3University of Arizona, Stockton, NJ, 4University of Arizona, Tucson, 5The University of Arizona Arthritis Center, University of Arizona, Tucson, 6Brigham and Women’s Hospital, Boston, MA, 7The University of Arizona Arthritis Center, University of Arizona, Tucson, AZ

Meeting: ACR Convergence 2025

Keywords: Biomarkers, Inflammation, Magnetic resonance imaging (MRI), Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2079–2105) Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Even though knee pain is ubiquitous in knee osteoarthritis (KOA) patients, currently there are limited treatment options which are only minimally or moderately efficacious for relieving pain and may lead to undesired side effects. Effusion-synovitis (ES) is present during all stages of OA and has been reported to be associated with increased knee pain. Though the validated WOMAC-Pain subscale was the primary assessment tool in most of these studies, it was used as a composite measure (i.e., only the total score was reported) so the associations between ES and pain during specific types of activities are unknown. Therefore, the main objective of this study is to evaluate the longitudinal associations between MRI-detected quantitative ES (qES) and self-reported total and activity-specific knee pain.

Methods: This study included a random longitudinal subsample of Osteoarthritis Initiative (OAI) participants with diagnosed radiographic KOA (Kellgren-Lawrence [KL] grade 2,3) who had both X-ray and MRI assessments of both knees at baseline (n = 534). Our primary outcome was self-reported knee pain in the past 7 days, reported at baseline, 12-, and 24-month visits for each knee. Knee pain was measured using the WOMAC-Pain and Knee injury and Osteoarthritis Outcome Score (KOOS) Pain subscales. The questions on both subscales were scored from 0-4, which correspond to: None (0), Mild (1), Moderate (2), Severe (3), and Extreme (4). Our primary exposure was whole knee joint qES, assessed on non-contrast enhanced 3T MRI at baseline, 12-, and 24-month visits. Total qES volume (mm3) was measured using our semi-automated multi-planar MRI quantification approach. We applied generalized estimating equations to evaluate the association between qES and the individual items of both subscales. These models were fitted using a multinomial distribution with a cumulative logit link function and unadjusted and adjusted odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were reported. We adjusted for age, gender, ethnicity, previous knee injury/surgery, BMI, and KL grade. The ORs and adjusted ORs and their associated 95% CIs were reported per a 5000 mm3 increase in qES.

Results: Whole-knee ES was significantly associated with the total WOMAC-Pain subscale score in the unadjusted and adjusted models. As shown in Figure 1, participants with greater qES had higher odds of experiencing worse knee pain (OR: 1.43 [1.15,1.77], adjusted OR: 1.37 [1.09, 1.70]). Regarding pain with specific activities, qES was significantly associated with knee pain at night while in bed (OR: 1.22 [1.08, 1.38], adjusted OR: 1.22 [1.08, 1.37]) and when going up or down the stairs (OR: 1.22 [1.08, 1.38], adjusted OR: 1.21 [1.07, 1.37]), as also shown in Figure 1. There was no significant association between pain with the three KOOS-specific activities and qES (Figure 2).

Conclusion: For KOA patients, longitudinal whole-knee qES was significantly associated with total WOMAC-Pain and particularly with knee pain during bedtime and climbing stairs. Our whole knee qES measure may be valuable for patient screening/phenotyping and outcome assessment in KOA trials.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: D. Robles: None; G. Gilles: None; N. Christiansen: None; L. Grawer: None; K. Jayyusi: None; A. Shaikh: None; R. Tang: None; M. Taljanovic: None; J. Duryea: None; E. Bedrick: None; C. Kwoh: Apos Health, 1, 2, Express Scripts, 1, 2, Kolon Tissue Gene, 2, Mobieus Sun, 1, 2, TLC, 1, 2, Xalud, 1, 2.

To cite this abstract in AMA style:

Robles D, Gilles G, Christiansen N, Grawer L, Jayyusi K, Shaikh A, Tang R, Taljanovic M, Duryea J, Bedrick E, Kwoh C. Estimating the Association between Effusion-synovitis and Knee Pain in a Subset of Participants with Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative (OAI) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/estimating-the-association-between-effusion-synovitis-and-knee-pain-in-a-subset-of-participants-with-radiographic-knee-osteoarthritis-data-from-the-osteoarthritis-initiative-oai/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/estimating-the-association-between-effusion-synovitis-and-knee-pain-in-a-subset-of-participants-with-radiographic-knee-osteoarthritis-data-from-the-osteoarthritis-initiative-oai/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology